Prostate biopsy strategies: Past, present, and future

Urologic Clinics of North America

Volumn 29, Issue 1, 2002, Pages 205-212

  Terris, Martha K ^a,b  

^a VA PALO ALTO HEALTH CARE SYSTEM   (United States)

^b STANFORD UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CONFERENCE PAPER; DIAGNOSTIC ACCURACY; DIAGNOSTIC IMAGING; ECHOGRAPHY; IMPEDANCE; NEPHROLITHIASIS; PRIORITY JOURNAL; PROSTATE BIOPSY; PROSTATE CANCER; SENSITIVITY AND SPECIFICITY; SURGICAL TECHNIQUE; TRANSRECTAL ULTRASONOGRAPHY;

BIOPSY; DECISION TREES; HUMANS; MALE; PROSTATE; PROSTATIC NEOPLASMS;

EID: 0036306760     PISSN: 00940143     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0094-0143(02)00005-8     Document Type: Conference Paper

References (54)

1. The use of ultrasound for localizing renal calculi
2. Diagnostic application of the ultrasonotomography for the prostate
3. Prediction of radical prostatectomy specimen pathology by lateral sextant biopsies compared to midlobe sextant biopsies
4. Prostatic-specific antigen: An immunohistologic marker for prostatic neoplasms
5. Transrectal ultrasound in the diagnosis of prostate cancer: Location, echogenicity, histopathology, and staging
6. Ultrasound-guided prostate biopsy: Biopsy gun superior to aspiration
7. Ultrasound guided transrectal core biopsies of the palpably abnormal prostate
8. Random-systematic versus directed ultrasound-guided core-biopsies of the prostate
9. Prostate cancer: The role of transrectal ultrasound and its impact on cancer detection and management
10. Making the most out of six systematic sextant biopsies
11. Prospective evaluation of lateral biopsies of the peripheral zone for prostate cancer detection
12. Optimization of prostate biopsy strategy using computer based analysis
13. Repeat prostate needle biopsy: Who needs it?
14. Serial prostatic biopsies in men with persistently elevated serum prostate specific antigen values
15. Two consecutive sets of transrectal ultrasound guided sextant biopsies of the prostate for the detection of prostate cancer
16. The sextant protocol for ultrasound-guided core biopsies of the prostate underestimates the presence of cancer
17. Diagnostic yield of repeated transrectal ultrasound-guided biopsies stratified by specific histopathologic diagnoses and prostate specific antigen levels
18. Sensitivity and specificity of transrectal ultrasound guided sextant biopsies: Preliminary report
19. Extensive repeat transrectal ultrasound guided prostate biopsy in patients with previous benign sextant biopsies
20. Systematic 5 region prostate biopsy is superior to sextant method for diagnosing carcinoma of the prostate
21. Results of a prospective randomized study comparing 6, 12, and 18 transrectal ultrasound guided sextant biopsies in patients with elevated PSA, normal DRE, and normal prostatic ultrasound
22. Use of three additional midbiopsies to improve local assessment of prostate cancer in patients with one positive sextant biopsy
23. Transrectal ultrasound imaging and ultrasound-guided prostate biopsies in the detection of residual carcinoma in clinical stage A carcinoma of the prostate
24. Detection of clinically significant prostate cancer by transrectal ultrasound-guided systematic biopsies
25. Indications for ultrasound-guided transition zone biopsies in the detection of prostate cancer
26. Routine performance of transition zone and seminal vesicle biopsies in all patients undergoing transrectal ultrasound guided prostate biopsies is not indicated
27. Value of systematic transition zone biopsies in the early detection of prostate cancer
28. Indications for transition zone biopsy in the detection of prostatic carcinoma
29. Critical evaluation of the current indications for transition zone biopsies
30. Extended field prostate biopsy enhances cancer detection
31. Prostatic transition zone biopsies in men with previous negative biopsies and persistently elevated serum prostate specific antigen values
32. Comparison of lateral versus midlobe systematic sextant biopsies in the detection of prostate cancer
33. Prospective evaluation of systematic sextant transition zone biopsies in large prostates for cancer detection
34. Importance of posterolateral needle biopsies of the prostate in the detection of prostate cancer
35. Prospective randomized trial comparing 6 versus 12 cores: Impact on cancer detection
36. New biopsy strategy detects prostate cancers missed by conventional sextant biopsies
37. Extended field prostate biopsies: Too much of a good thing?
38. Using gray-scale and color and power Doppler sonography to detect prostatic cancer
39. Prostatic cancer: Role of color Doppler imaging in transrectal sonography
40. Prostate cancer: Diagnosis with color Doppler sonography with histologic correlation of each biopsy site
41. Prostate: Techniques, results, and potential applications of color Doppler US scanning
42. Contrast-enhanced three-dimensional power Doppler angiography of the human prostate: Correlation with biopsy outcome
43. Peripheral hypoechoic lesions of the prostate: Evaluation with color and power Doppler ultrasound
44. Initial experience with contrast-enhanced sonography of the prostate
45. Three-dimensional US of the prostate: Early experience
46. Tissue optics
47. Optical time-of-flight and absorbance imaging of biologic media
48. An electrical impedance index to distinguish between normal and cancerous tissues
49. Ex vivo discrimination between normal and pathological tissues in human breast surgical biopsies using bioimpedance spectroscopy
50. Noninvasive measurement of the electrical bioimpedance of breast tumors
51. Spectroscopic identification of prostatic abnormalities during prostate biopsy
52. Bioimpedance: Novel use of a minimally invasive technique for cancer localization in the intact prostate
53. Visualizing gene expression in living mammals using a bioluminescent reporter
54. Hydrophilic cyanine dyes as contrast agents for near-infrared tumor imaging: Synthesis, photophysical properties and spectroscopic in vivo characterization